News

Medical Devices

3 Stocks to Watch Ahead of Earnings

3 Stocks to Watch Ahead of Earnings

Harry Boxer | Equities.com |

These three health and technology stocks are seeing technical strength ahead of upcoming earnings.


University of Alberta Researchers Identify a New Gene that Causes Glaucoma

Edward Kim | Equities.com |

We're following several companies pursuing next generation glaucoma treatments.


Eyenovia Shows Positive Phase 3 Results in Pupil Dilation Device

Edward Kim | Equities.com |

80 million annual exams in the US involve mydriasis (pupil dilation)


BioCardia Submits FDA Application for New Steerable Cardiovascular Introducer

Edward Kim | Equities.com |

The AVANCE is designed to introduce cardiovascular catheters into the heart, including via the interatrial septum (Image: BioCardia)


Generex Acquires Majority Stake in Olaregen Therapeutix to Enter Wound Healing Market

Edward Kim | Equities.com |

Olaregen's Excellagen (flowable dermal matrix) is FDA approved for wound management in multiple indications (Image: Olaregen Therapeutix)


Vapotherm's $60 Million IPO Expected Next Week for Respiratory Distress Treatment Systems

Edward Kim | Equities.com |

Company markets the only mask-free, clinically validated alternative to the standard of care for respiratory distress (Image: Vapotherm)


Ra Medical Systems' $50 Million IPO Expected This Week

Edward Kim | Equities.com |

Excimer laser system to treat vascular and dermatological diseases (Image: Ra Medical Systems).


Endotronix Closes $45 Million Series D Round for Heart Failure Monitoring Solutions

Edward Kim | Equities.com |

Heart data transmitted to the clinician for timely heart failure monitoring and management (Image: Endotronix).


Renovia Raises $42.3 Million Series B for Pelvic Floor Disorders

Edward Kim | Equities.com |

The company markets the leva pelvic floor muscle training system to help patients maintain continence (Image: Renovia).


Novocure Partners with US Oncology Research for Phase 3 Trial in Pancreatic Cancer

Edward Kim | Equities.com |

Study will test combination of Novocure's Tumor Treating Fields device and chemotherapy (Image: Novocure).


World Economic Forum at Davos 2019 - Joseph Weinberg CEO PayCase, Chairman Shyft

Matt Bird sits down with Joseph Weinberg CEO PayCase, Chairman Shyft at the World Economic Forum at Davos 2019


Events

National Investment Banking Association

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at the The Westin New York at Times Square in New York,…

Learn more